Health

FDA Approves Harliku (nitisinone) for the Treatment of Patients with Alkaptonuria

DailyTrendDailyTrend
Jun 24, 2025 - 01:00
 0  0
FDA Approves Harliku (nitisinone) for the Treatment of Patients with Alkaptonuria
BOSTON, Massachusetts and Cambridge, UK – June 19, 2025 – Cycle Pharmaceuticals announced that the FDA has approved Harliku (nitisinone) Tablets for the reduction of urine homogentisic acid (HGA) in adult patients with AKU.1 Launching...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

How Medicaid Cuts Could Force Disabled Americans Into Institutions

How Medicaid Cuts Could Force Disabled Americans Into I...

DailyTrend Aug 20, 2025  0  0

Wegovy Granted Accelerated Approval in the US for the Treatment of MASH

Wegovy Granted Accelerated Approval in the US for the T...

DailyTrend Aug 18, 2025  0  0

A 1990 Measles Outbreak Shows How the Disease Can Roar Back

A 1990 Measles Outbreak Shows How the Disease Can Roar ...

DailyTrend Aug 21, 2025  0  0

The Madden Sisters Don’t Want to Be Institutionalized

The Madden Sisters Don’t Want to Be Institutionalized

DailyTrend Aug 18, 2025  0  0

B. Braun Medical Issues Voluntary Nationwide Recall of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL Due to the Presence of Particulate Matter

B. Braun Medical Issues Voluntary Nationwide Recall of ...

DailyTrend Aug 20, 2025  0  0

Cases of Mosquito-Borne Chikungunya Virus Are Surging Globally: What to Know

Cases of Mosquito-Borne Chikungunya Virus Are Surging G...

DailyTrend Aug 19, 2025  0  0